View Past PerformanceBio Essence バランスシートの健全性財務の健全性 基準チェック /56Bio Essenceの総株主資本は$2.3M 、総負債は$56.8Kで、負債比率は2.4%となります。総資産と総負債はそれぞれ$4.0Mと$1.7Mです。 Bio Essenceの EBIT は$1.5Mで、利息カバレッジ比率-2186です。現金および短期投資は$675.0です。主要情報2.43%負債資本比率US$56.84k負債インタレスト・カバレッジ・レシオ-2186x現金US$675.00エクイティUS$2.34m負債合計US$1.66m総資産US$4.00m財務の健全性に関する最新情報お知らせ • Aug 15Bio Essence Corporation announced delayed 10-Q filingOn 08/14/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Bio Essence Corporation announced delayed 10-Q filingOn 05/15/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 29Bio Essence Corporation announced delayed annual 10-K filingOn 03/27/2024, Bio Essence Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.すべての更新を表示Recent updatesお知らせ • Oct 18Bio Essence Corporation has filed a Follow-on Equity Offering in the amount of $5 million.Bio Essence Corporation has filed a Follow-on Equity Offering in the amount of $5 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 100,000,000 Price\Range: $0.05 Discount Per Security: $0.0089お知らせ • Aug 15Bio Essence Corporation announced delayed 10-Q filingOn 08/14/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 17Bio Essence Corporation announced delayed 10-Q filingOn 05/15/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 05Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation (OTCPK:BIOE) on for $0.4 millionHealth Up, Inc entered into an agreement to acquire Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation (OTCPK:BIOE) on for $0.4 million March 28, 2024. The Board of Directors of Bio Essence Corporation approved the sale pursuant to a Consent Resolution dated March 28, 2024. The transaction is expected to close on March 31, 2024. Health Up, Inc completed the acquisition of Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation (OTCPK:BIOE) on April 1, 2024.お知らせ • Mar 29Bio Essence Corporation announced delayed annual 10-K filingOn 03/27/2024, Bio Essence Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Dec 14+ 1 more updateBio Essence Corporation Announces Resignation of Sharon Mair from the Board of DirectorsOn December 8, 2023, Bio Essence Corporation received notice from Sharon Mair, a member of the Company’s Board of Directors, that she resigned from the Board of Directors effective immediately.お知らせ • Sep 09Bio Essence Corporation Appoints William E. Sluss as Chief Financial OfficerOn September 7, 2023, William E. Sluss was appointed as Chief Financial Officer (Principal Financial Officer) of Bio Essence Corp. (the Company). Mr. Sluss has served as a Financial Executive for both private and publicly traded companies over the last thirty years. Most recently, he has served as director and Chief Financial Officer for Black Bird Biotech Inc. located in Flower Mound, Texas. Prior to joining Black Bird Biotech Inc., Mr. Sluss was the Chief Financial Officer and Secretary for EFT Holdings Inc., a manufacturer and distributor of beauty and nutritional products headquartered in Los Angeles California. Prior to relocating to Los Angeles, California in 2010, Mr. Sluss served as the Chief Financial Officer for AccuForce Staffing Services in Kingsport, Tennessee. Prior to this role, Mr. Sluss was the Chief Financial Officer and Treasurer for Studsvik Inc., a nuclear services company based in Erwin, Tennessee. In addition to serving as a Financial Executive, Mr. Sluss has worked as an attorney at Ecoff Campain Tilles & Kay, LLP in Beverly Hills, California where he oversaw corporate and civil litigation. He is a licensed Certified Public Accountant and received his Bachelor of Science degree in accounting from the University of Virginia’s College at Wise in 1990. Mr. Sluss received his Juris Doctorate degree from Irvine University College of Law in 2020. Mr. Sluss is a licensed attorney and member of the California Bar.財務状況分析短期負債: BIOEの 短期資産 ( $606.5K ) は 短期負債 ( $1.6M ) をカバーしていません。長期負債: BIOEの短期資産 ( $606.5K ) が 長期負債 ( $55.4K ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: BIOEの 純負債対資本比率 ( 2.4% ) は 満足できる 水準であると考えられます。負債の削減: BIOEは 5 年前には株主資本がマイナスでしたが、現在はプラスになっており、改善されています。債務返済能力: BIOEの負債は 営業キャッシュフロー によって 十分にカバー されています ( 1892.6% )。インタレストカバレッジ: BIOE支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/17 16:08終値2026/08/17 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bio Essence Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 15Bio Essence Corporation announced delayed 10-Q filingOn 08/14/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Bio Essence Corporation announced delayed 10-Q filingOn 05/15/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 29Bio Essence Corporation announced delayed annual 10-K filingOn 03/27/2024, Bio Essence Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Oct 18Bio Essence Corporation has filed a Follow-on Equity Offering in the amount of $5 million.Bio Essence Corporation has filed a Follow-on Equity Offering in the amount of $5 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 100,000,000 Price\Range: $0.05 Discount Per Security: $0.0089
お知らせ • Aug 15Bio Essence Corporation announced delayed 10-Q filingOn 08/14/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 17Bio Essence Corporation announced delayed 10-Q filingOn 05/15/2024, Bio Essence Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 05Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation (OTCPK:BIOE) on for $0.4 millionHealth Up, Inc entered into an agreement to acquire Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation (OTCPK:BIOE) on for $0.4 million March 28, 2024. The Board of Directors of Bio Essence Corporation approved the sale pursuant to a Consent Resolution dated March 28, 2024. The transaction is expected to close on March 31, 2024. Health Up, Inc completed the acquisition of Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation (OTCPK:BIOE) on April 1, 2024.
お知らせ • Mar 29Bio Essence Corporation announced delayed annual 10-K filingOn 03/27/2024, Bio Essence Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Dec 14+ 1 more updateBio Essence Corporation Announces Resignation of Sharon Mair from the Board of DirectorsOn December 8, 2023, Bio Essence Corporation received notice from Sharon Mair, a member of the Company’s Board of Directors, that she resigned from the Board of Directors effective immediately.
お知らせ • Sep 09Bio Essence Corporation Appoints William E. Sluss as Chief Financial OfficerOn September 7, 2023, William E. Sluss was appointed as Chief Financial Officer (Principal Financial Officer) of Bio Essence Corp. (the Company). Mr. Sluss has served as a Financial Executive for both private and publicly traded companies over the last thirty years. Most recently, he has served as director and Chief Financial Officer for Black Bird Biotech Inc. located in Flower Mound, Texas. Prior to joining Black Bird Biotech Inc., Mr. Sluss was the Chief Financial Officer and Secretary for EFT Holdings Inc., a manufacturer and distributor of beauty and nutritional products headquartered in Los Angeles California. Prior to relocating to Los Angeles, California in 2010, Mr. Sluss served as the Chief Financial Officer for AccuForce Staffing Services in Kingsport, Tennessee. Prior to this role, Mr. Sluss was the Chief Financial Officer and Treasurer for Studsvik Inc., a nuclear services company based in Erwin, Tennessee. In addition to serving as a Financial Executive, Mr. Sluss has worked as an attorney at Ecoff Campain Tilles & Kay, LLP in Beverly Hills, California where he oversaw corporate and civil litigation. He is a licensed Certified Public Accountant and received his Bachelor of Science degree in accounting from the University of Virginia’s College at Wise in 1990. Mr. Sluss received his Juris Doctorate degree from Irvine University College of Law in 2020. Mr. Sluss is a licensed attorney and member of the California Bar.